December 09, 2024

CLEAR Trial: Evaluating Spironolactone in Post-MI Care

A recent study evaluated the routine use of spironolactone in patients with myocardial infarction to assess its effect on cardiovascular outcomes.

Conexiant

December 04, 2024

Artery Block May Cut Knee Pain by 71%

“This could potentially offer a new lease on life for many patients who suffer from debilitating pain and mobility issues caused by osteoarthritis.”

Reuters

December 02, 2024

Can Hidden Fat Predict Alzheimer's Risk?

A study presented at RSNA 2024 demonstrated findings at midlife, decades prior to patients exhibiting early symptoms of Alzheimer's disease related dementia.

Conexiant

November 26, 2024

Nicotine-Free Vaping Altered Blood Flow, Study Shows

Nicotine-free vaping showed immediate vascular effects, with MRI revealing a significant decrease in femoral artery blood flow and oxygen saturation post-inhalation (P<0.05), challenging assumptions about its comparative safety.

Conexiant

May 01, 2024

Cathie Biga, MSN, FACC, Named President of ACC

Cathie Biga, MSN, FACC, has been elected the 2024 to 2025 President of the American College of Cardiology (ACC).

Conexiant

May 15, 2024

ACC 2024: Can an App Improve Access to Nonprescription Statins?

A novel web-based application designed to qualify patients with high low-density lipoprotein (LDL) cholesterol for treatment with nonprescription statins may be comparable to physician assessment.

Conexiant

July 01, 2024

Mediterranean & DASH Diets May Lower Cardiovascular Risk in T1D

More closely following Mediterranean or DASH diets may be linked to lower cardiovascular disease risk

Conexiant

June 21, 2024

Salsalate for T1D Neuropathy: Phase 2 Trial Results

Can an old drug learn new tricks?

Conexiant

June 27, 2024

Analysis Evaluates Safety Profile of Enobosarm

A pooled analysis revealed insights on adverse events experienced by patients taking enobosarm, a selective androgen receptor modulator, vs a placebo.

Conexiant